GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (OTCPK:INRLF) » Definitions » Cyclically Adjusted Revenue per Share

INRLF (Valneva SE) Cyclically Adjusted Revenue per Share : $0.00 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Valneva SE's adjusted revenue per share for the three months ended in Mar. 2025 was $0.346. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Valneva SE's average Cyclically Adjusted Revenue Growth Rate was 3.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Valneva SE was 17.60% per year. The lowest was 10.00% per year. And the median was 16.20% per year.

As of today (2025-05-14), Valneva SE's current stock price is $3.25. Valneva SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $0.00. Valneva SE's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Valneva SE was 23.42. The lowest was 1.00. And the median was 3.79.


Valneva SE Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Valneva SE's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Cyclically Adjusted Revenue per Share Chart

Valneva SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 1.56 1.81 1.92 1.79

Valneva SE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 1.96 2.07 1.79 -

Competitive Comparison of Valneva SE's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Valneva SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Valneva SE's Cyclically Adjusted PS Ratio falls into.


;
;

Valneva SE Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Valneva SE's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.346/120.1600*120.1600
=0.346

Current CPI (Mar. 2025) = 120.1600.

Valneva SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.283 100.440 0.339
201509 0.307 99.950 0.369
201512 0.305 100.040 0.366
201603 0.367 100.020 0.441
201606 0.389 100.630 0.464
201609 0.265 100.340 0.317
201612 0.372 100.650 0.444
201703 0.367 101.170 0.436
201706 0.317 101.320 0.376
201709 0.311 101.330 0.369
201712 0.453 101.850 0.534
201803 0.543 102.750 0.635
201806 0.380 103.370 0.442
201809 0.295 103.560 0.342
201812 0.479 103.470 0.556
201903 0.406 103.890 0.470
201906 0.352 104.580 0.404
201909 0.355 104.500 0.408
201912 0.403 104.980 0.461
202003 0.423 104.590 0.486
202006 0.157 104.790 0.180
202009 0.147 104.550 0.169
202012 0.681 104.960 0.780
202103 0.299 105.750 0.340
202106 0.300 106.340 0.339
202109 0.253 106.810 0.285
202112 3.257 107.850 3.629
202203 0.222 110.490 0.241
202206 0.695 112.550 0.742
202209 1.464 112.740 1.560
202212 0.850 114.160 0.895
202303 0.257 116.790 0.264
202306 0.309 117.650 0.316
202309 0.300 118.260 0.305
202312 0.329 118.390 0.334
202403 0.248 119.470 0.249
202406 0.294 120.200 0.294
202409 0.331 119.560 0.333
202412 0.325 119.950 0.326
202503 0.346 120.160 0.346

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Valneva SE  (OTCPK:INRLF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Valneva SE was 23.42. The lowest was 1.00. And the median was 3.79.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Valneva SE Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Valneva SE's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (OTCPK:INRLF) » Definitions » Cyclically Adjusted Revenue per Share
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.